A healthcare provider (hcp) for a clinical study reported the patient remained hospitalized after implant for nausea, vomiting, and uncontrolled hypertension due to her inability to take oral medication for hypertension.The patient was admitted to the floor post-operation and given npo (nil per os) status post-surgery secondary to no return of bowel function, the patient spitting up, and she was unable to take her home dose of labetalol and her blood pressure became uncontrollably elevated.The patient was transferred to the surgical intensive care unit and placed on a nicardipine drip.She was also started on erythromycin and thereafter resumed bowel function.Her blood pressure stabilized and she was able to tolerate po (per os - oral administration of medication).Her home po labetalol was restarted and she was then transferred back to the floor.Her blood pressure was stable on the floor and she was deemed stable for discharge with restart of her insulin pump, outpatient endocrine follow up, and follow up with her physician in a week as an outpatient.The problem was not with the patient's device.The nausea, vomiting, and hypertension resolved.If additional information is received, a follow-up report will be sent.
|